Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedApr 17, 2025
DataAggregated Company Financials
Companies41
  • 7D3.7%
  • 3M-6.4%
  • 1Y-1.7%
  • YTD-9.6%

In the last week, the Pharma industry is up 3.7%, with Chugai Pharmaceutical up 6.2%. The industry has been flat over the past 12 months despite the gain this week. Earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Apr 2025JP¥37.4tJP¥16.5tJP¥1.5t14.2x24.8x2.3x
Sat, 15 Mar 2025JP¥39.9tJP¥16.5tJP¥1.5t16x26.5x2.4x
Mon, 10 Feb 2025JP¥40.2tJP¥16.4tJP¥1.3t15.2x30.7x2.5x
Wed, 08 Jan 2025JP¥41.9tJP¥16.1tJP¥1.4t16.3x29.7x2.6x
Fri, 06 Dec 2024JP¥43.0tJP¥16.1tJP¥1.4t15.3x30.5x2.7x
Sun, 03 Nov 2024JP¥45.0tJP¥16.0tJP¥1.4t15.8x32.3x2.8x
Tue, 01 Oct 2024JP¥43.0tJP¥15.5tJP¥1.2t15.8x35.8x2.8x
Thu, 29 Aug 2024JP¥48.2tJP¥15.5tJP¥1.2t17.9x40.1x3.1x
Sat, 27 Jul 2024JP¥44.8tJP¥15.0tJP¥1.1t18.4x40.9x3x
Mon, 24 Jun 2024JP¥40.5tJP¥15.0tJP¥1.1t17.8x37x2.7x
Wed, 22 May 2024JP¥40.9tJP¥15.0tJP¥1.1t16.6x37.4x2.7x
Fri, 19 Apr 2024JP¥38.8tJP¥14.8tJP¥1.2t18.6x32.2x2.6x
Sun, 17 Mar 2024JP¥42.6tJP¥15.1tJP¥1.2t19.7x35.1x2.8x
Tue, 13 Feb 2024JP¥41.0tJP¥15.0tJP¥1.3t20.1x32x2.7x
Thu, 11 Jan 2024JP¥41.5tJP¥15.2tJP¥1.4t20.3x30.2x2.7x
Sat, 09 Dec 2023JP¥39.5tJP¥15.2tJP¥1.4t20.1x28.7x2.6x
Mon, 06 Nov 2023JP¥38.8tJP¥15.1tJP¥1.3t22.4x28.9x2.6x
Wed, 04 Oct 2023JP¥39.8tJP¥14.9tJP¥1.4t23.2x27.9x2.7x
Fri, 01 Sep 2023JP¥40.8tJP¥14.9tJP¥1.4t23.3x28.5x2.7x
Sun, 30 Jul 2023JP¥38.7tJP¥14.7tJP¥1.5t20.8x26.5x2.6x
Tue, 27 Jun 2023JP¥40.7tJP¥14.6tJP¥1.5t20.8x27.8x2.8x
Thu, 25 May 2023JP¥40.3tJP¥14.6tJP¥1.5t19.7x27.6x2.8x
Sat, 22 Apr 2023JP¥38.2tJP¥14.3tJP¥1.5t17.8x26x2.7x
Mon, 20 Mar 2023JP¥37.1tJP¥14.3tJP¥1.5t16.5x25.3x2.6x
Wed, 15 Feb 2023JP¥37.1tJP¥14.3tJP¥1.4t17.6x25.7x2.6x
Fri, 13 Jan 2023JP¥36.1tJP¥13.7tJP¥1.3t17.3x26.8x2.6x
Sun, 11 Dec 2022JP¥39.3tJP¥13.7tJP¥1.3t18.6x29.1x2.9x
Tue, 08 Nov 2022JP¥38.4tJP¥13.6tJP¥1.4t17.6x27.9x2.8x
Thu, 06 Oct 2022JP¥38.3tJP¥13.3tJP¥1.4t18.2x26.7x2.9x
Sat, 03 Sep 2022JP¥36.7tJP¥13.3tJP¥1.4t17.7x25.6x2.8x
Mon, 01 Aug 2022JP¥36.7tJP¥13.2tJP¥1.4t18x25.5x2.8x
Wed, 29 Jun 2022JP¥36.1tJP¥13.1tJP¥1.5t18.1x24.7x2.8x
Fri, 27 May 2022JP¥34.9tJP¥13.1tJP¥1.5t17.9x23.9x2.7x
Sun, 24 Apr 2022JP¥35.2tJP¥12.8tJP¥1.5t20.4x22.7x2.7x
Price to Earnings Ratio

22.7x


Total Market Cap: JP¥35.2tTotal Earnings: JP¥1.5tTotal Revenue: JP¥12.8tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Price to Earnings3Y Average 29.4x202320242025
Current Industry PE
  • Investors are pessimistic on the Japanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.8x which is lower than its 3-year average PE of 29.4x.
  • The 3-year average PS ratio of 2.7x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 8.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market6.32%
Healthcare3.88%
Pharma3.73%
Pharma3.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4519 Chugai PharmaceuticalJP¥7.09k5.5%
+JP¥603.9b
39.2%PE30.1x
4502 Takeda PharmaceuticalJP¥4.17k1.2%
+JP¥73.4b
1.9%PE30.6x
4507 ShionogiJP¥2.37k3.0%
+JP¥59.1b
-0.6%PE11.9x
4523 EisaiJP¥3.89k4.6%
+JP¥48.5b
-33.2%PE18.6x
4151 Kyowa KirinJP¥2.19k3.4%
+JP¥38.2b
-16.7%PE19.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4568

JP¥3,100.00

Daiichi Sankyo Company

7D

-5.7%

1Y

-31.7%

4519

JP¥7,085.00

Chugai Pharmaceutical

7D

5.5%

1Y

39.2%

4523

JP¥3,888.00

Eisai

7D

4.6%

1Y

-33.2%

4577

JP¥2,010.00

Daito PharmaceuticalLtd

7D

-6.8%

1Y

-19.2%

4530

JP¥4,450.00

Hisamitsu Pharmaceutical

7D

11.7%

1Y

19.0%

4503

JP¥1,327.00

Astellas Pharma

7D

-0.5%

1Y

-9.5%

4507

JP¥2,367.00

Shionogi

7D

3.0%

1Y

-0.6%

4502

JP¥4,168.00

Takeda Pharmaceutical

7D

1.2%

1Y

1.9%

4547

JP¥3,595.00

Kissei Pharmaceutical

7D

-2.2%

1Y

3.5%

4540

JP¥4,281.00

Tsumura

7D

3.5%

1Y

11.2%

4534

JP¥2,942.00

Mochida Pharmaceutical

7D

-2.9%

1Y

-5.6%

4536

JP¥1,384.50

Santen Pharmaceutical

7D

-1.4%

1Y

-4.1%